Output of traditional Tibetan medicine rose to 2,300 tons, valued at 1.5 billion yuan (217 million U.S. dollars) in 2016, due to growing demand for the ancient medicine.
Twenty-one pharmaceutical companies in southwest China's Tibet Autonomous Region have been awarded the certificate of Good Manufacturing Practices for Pharmaceutical Products, according to the region's Commission of Industry and Information Technology Tuesday.
To meet rising demand, the cultivation area of traditional medicine across the region increased by about 200 hectares in 2016.
Tibet will increase investment in Tibetan medicine research, build more R&D centers, expand cultivation and enhance production technology in 2017, according to Qiu Chuan, deputy head of the commission.
Tibetan medicine, known as "Sowa Rigpa" in Tibetan, is at least 2,300 years old. It has absorbed the influences of traditional Chinese, Indian and Arab medicine, and is mainly practiced in Tibet and the Himalayan region.
Tibetan medicine uses herbs, minerals and sometimes insects and animal parts. It was put on the list of China's national intangible cultural heritage in 2006.
